Maintenance therapy in the treatment of metastatic colorectal cancer. Axel Grothey, MD
Grothey, A.
Oncology 29(8): 560; 594
2015
ISSN/ISBN: 0890-9091 PMID: 26349341 Document Number: 682316
Document emailed within 1 workday
Related Documents
Marshall, J.L. 2014: Maintenance therapy in metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 12(6): 388-390Kemeny, N.E. 2000: Hepatic arterial therapy for the treatment of metastatic colorectal cancer Seminars in Oncology 27(5 Suppl 10: 126-131
2013: Danitumumab adjunctive therapy. No place in either first- or second-line treatment of metastatic colorectal cancer Prescrire International 22(138): 120
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Turja, J.; Grothey, A. 2008: Individualizing therapy for metastatic colorectal cancer Oncology 22(13): 1479-1481
Pfeiffer, P.; Jensen, B.V. 2005: Drug therapy of patients with metastatic colorectal cancer Ugeskrift for Laeger 167(45): 4261-4265
Kato, K. 2011: Development of oral drugs in the standard therapy for metastatic colorectal cancer patients Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 454-458
Weinberg, B.A.; Marshall, J.L.; Hartley, M.; Salem, M.E. 2016: A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer Clinical Advances in Hematology and Oncology: H&o 14(2): 116-128
Lee, J.J.; Sun, W. 2016: Options for Second-Line Treatment in Metastatic Colorectal Cancer Clinical Advances in Hematology and Oncology: H&o 14(1): 46-54
Pfeiffer, P.; Qvortrup, C.; Hansen, T.P. 2009: Tailored treatment to patients with metastatic colorectal cancer Ugeskrift for Laeger 171(13): 1098
Takano, J.; Matsuhashi, N.; Takahashi, T.; Tanahashi, T.; Matsui, S.; Imai, H.; Tanaka, Y.; Yamaguchi, K.; Yoshida, K. 2018: A Case of Metastatic Colorectal Cancer with Brain Metastasis Treated with Combined TFTD and Bevacizumab Therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(2): 318-320
Sasaki, K.; Takasaka, H.; Nishikawa, N.; Yoshikawa, T.; Hirata, K. 2003: Home chemotherapy and outpatient treatment for metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 7): 333-337
Al-Hajeili, M.; Marshall, J.L.; Smaglo, B.G. 2016: Neoadjuvant Treatment for Surgically Resectable Metastatic Colorectal Cancer Oncology 30(1): 10-16
Halámková, J.; Tomášek, J.; Rybníčková, S.; Adámková Krákorová, D.; Bencsiková, B.; Kiss, I. 2013: The current approach to the treatment of the patients with metastatic colorectal cancer Vnitrni Lekarstvi 59(10): 903-908
Otani, Y.; Kondo, T.; Saito, R.; Matsumura, Y.; Ohura, H.; Hirose, M.; Horikoshi, A.; Sado, T.; Sugita, M.; Okaniwa, G. 1995: Surgical treatment of metastatic lung tumor from colorectal cancer Kyobu Geka. Japanese Journal of Thoracic Surgery 48(9): 735-740
Hibi, S.; Ina, K.; Furuta, R.; Kataoka, T.; Kojima, S.; Kawai, M. 2009: Clinical effects of Hange-shashin-to on combination therapy of S-1/irinotecan against the for patients with metastatic gastric and colorectal cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(9): 1485-1488
Takiuchi, H. 2010: Current status and perspectives of biologics in the treatment of metastatic colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 68(10): 1866-1870
des Guetz, G.; Mariani, P.; Cucherousset, J.; Benamoun, M.; Lagorce, C.; Sastre, X.; Le Toumelin, P.; Uzzan, B.; Perret, G.Y.; Morere, J.F.; Breau, J.L.; Fagard, R.; Schischmanoff, P.O. 2007: Microsatellite instability and sensitivitiy to FOLFOX treatment in metastatic colorectal cancer Anticancer Research 27(4c): 2715-2719
Iwasa, S.; Shimada, Y. 2011: Treatment strategy of chemotherapy for unresectable metastatic or recurrent colorectal cancer Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 3): 427-432
Karacetin, D.; Yalcin, B.; Okten, B.; Ozturk, S.; Maral, O.; Incekara, O. 2009: Capecitabine and oxaliplatin (XELOX) as first-line treatment for patients with metastatic colorectal cancer Journal of BUON: Official Journal of the Balkan Union of Oncology 14(4): 605-608